Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What is the Projected CAGR for the Amebiasis Market Size from 2025 to 2034?

The market value for amebiasis has experienced substantial growth in the past few years. It is predicted to increase from $0.82 billion in 2024 to approximately $0.88 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to the growth during the historical period include the rise of amoebic infections in tropical areas, inadequate sanitation and hygiene conditions in developing countries, increased international travel particularly to endemic zones, heightened awareness concerning the illness, and a deficit of clean drinking water in rural regions.

The market size for amebiasis is set to witness robust growth in the upcoming years. By 2029, it is projected to reach $1.14 billion, with a compound annual growth rate (CAGR) of 6.6%. The predicted growth within this period can be credited to factors such as the growing number of immune-compromised individuals, increasing governmental actions to enhance sanitation and medical facilities, augmented fund allocation for researching novel treatments, enhanced importance on health initiatives to eradicate parasitic diseases, and an increased demand for efficient oral drugs. Significant trends in the forecast period encompass increasing acceptance of combination therapies, vaccine development, progress in drug delivery systems, advancements in pharmaceutical study, and the emergence of new antiprotozoal drugs.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21094&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Amebiasis Market?

The rise in parasitic infections is expected to fuel the growth of the amebiasis market in the future. These infections encompass diseases caused by parasites including protozoa, helminths, and ectoparasites, which thrive within or on a host, feeding off host resources. The uptick in parasitic infections can be attributed to numerous factors such as increased travel, changes in the climate, inadequate sanitation, and the emergence of drug-resistant parasites, which collectively enable the spread and persistence of these infections. Amebiasis is a parasitic infection caused by the entamoeba histolytica parasite, which attacks the intestines, resulting in diarrhea, abdominal pain, and potentially serious complications like tissue damage and liver abscesses. As an example, the Animal and Plant Health Agency, a government agency in the UK, reported 1,071 diagnoses of Parasitic Gastroenteritis (PGE) in 2022, of which 190 were cases of haemonchosis and 95 were cases of nematodirosis. The number of occurrences of haemonchosis in 2022 witnessed a considerable increase from the previous year. Hence, the surge in parasitic infections is contributing to the rise of the amebiasis market. The rising incidence of poor sanitation is projected to augment the growth of the amebiasis market. Poor sanitation signifies a lack of access to clean water, proper waste disposal systems, and sanitary facilities, which often result in the spread of diseases. The increasing rates of poor sanitation can be linked to elements such as insufficient infrastructure, improper waste management, and fast-paced urbanization. Amebiasis thrives in environments of poor sanitation, as the Entamoeba histolytica parasite proliferates in contaminated water and food sources. It spreads swiftly in environments that lack sufficient hygiene measures and waste management. As an illustration, in 2022, the United Nations Water, an agency in the US, stated that 2 billion people still lacked basic hygiene services, while 3.5 billion were without safely managed sanitation. Consequently, the growing issue of poor sanitation is a major contributing factor towards the expansion of the amebiasis market.

Which Primary Segments of the Amebiasis Market Are Driving Growth and Industry Transformations?

The amebiasis market covered in this report is segmented –

1) By Type: Metronidazole, Paromomycin, Tinidazole

2) By Route Of Administration: Oral, Intravenous

3) By Application: Hospital, Pharmacy

Subsegments:

1) By Metronidazole: Oral Metronidazole, Intravenous Metronidazole, Combination Therapy with Metronidazole

2) By Paromomycin: Oral Paromomycin, Paromomycin in Combination with Other Drugs

3) By Tinidazole: Oral Tinidazole, Tinidazole for Severe Infections

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21094&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Amebiasis Market?# Market?

North America was the largest region in the amebiasis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amebiasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Amebiasis Market?

Leading firms in the amebiasis market are zeroing in on the creation of sophisticated solutions such as pre-prepared oral liquid metronidazole, to enhance patient adherence and effectiveness of treatment. This ready-to-use liquid formulation of the antibiotic used for treating infections such as amebiasis, is intended to benefit patients who find it challenging to consume pills. Kesin Pharma Corporation, a pharmaceutical conglomerate based in the US, is one such example that got the stamp of approval from the U.S. Food and Drug Administration in November 2023 for Likmez (metronidazole) oral suspension – 500 mg/5 mL, confirming it as the premier ready-to-use oral liquid version of metronidazole. This oral suspension variant empowers a more child-friendly approach, simplifying accurate dosage for children and promoting increased adherence to treatment methodologies. The liquid version provides dosage flexibility, enabling healthcare professionals to tailor treatments as per the distinct needs of each patient, especially for varying degrees of infection severity.

View the full report here:

https://www.thebusinessresearchcompany.com/report/amebiasis-global-market-report

What Parameters Are Used to Define the Amebiasis Market?

Amebiasis refers to an intestinal infection caused by the parasite Entamoeba histolytica, often leading to symptoms such as diarrhea, abdominal pain, and sometimes liver abscesses. It is used for the treatment of this infection through medications such as metronidazole and tinidazole, which target the parasite in the gut and tissues.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21094

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model